• Rapid Detection of Viruses

    for Schools.

  • Rapid Detection of Viruses

    for Point of Care.

  • Rapid Detection of Viruses

    for Events.

  • Rapid Detection of Viruses

    for Travel.

  • Rapid Detection of Viruses

    for Nursing Homes.

COVID-19 & the Need for Rapid Diagnostics.

Viral pandemics such as COVID-19 are a rapidly emerging threat to global security and economic stability. Unlike bacterial infections which have a wide range of developed antibiotic therapies, new viral infections have very few pre-existing treatments. The World Health Organization has correspondingly noted a public health emergency and an urgent need for rapid diagnostics, vaccines and therapeutics to detect, prevent and contain the COVID-19 virus. The success of these remediation efforts will depend largely upon early detection, proactive and preventive measures, attempting to contain the rate of viral growth until customized treatments can be developed and made available.

The sobering reality is that modern medicine has limited treatment options to deal with new viral infections, instead relying on prevention and containment using quarantines and vaccination to keep the populous safe. Pandemics are large-scale outbreaks of infectious disease that can greatly increase morbidity and mortality over a wide geographic area and cause significant economic, social, and political disruption. The occurrence and severity of viral outbreaks has only increased over the past century as the world has become more interconnected with global travel, increased population density because of urbanization, and changes in land use.

Now more than ever the reality of an interconnected world means there is a desperate need to identify and stem the tide of emerging outbreaks quickly in order to prevent worldwide pandemics. Early intervention and investment into medical diagnostics is crucial for early detection and containment of new viruses to preserve the world economy


Single use, rapid virus test (strip or wipe) for the selective identification of Covid-19 that can give results within minutes.


Will be easy to use and require no special training.  The system is compatible with several simple formats including lateral flow tests, similar to using a pregnancy test.


Will allow for rapid reconfiguration, including the testing of any bodily fluid containing the virus and screening for multiple infections in just one test.


Planned to be compatible with detecting other components unique to a particular virus such as DNA, RNA, proteins, small molecules, and antibodies.


Based on a synthetic polymer, allowing for extended shelf life, minimal storage and handling requirements, and less sensitivity to temperature and light degradation relative to antibodies used in traditional immunoassay products.


Learn more about AMIPs™.

Want to learn more about AMIPs™? Check out Sixth Wave U’s video on the AMIPs™ system.

Partnership Opportunities.

We are currently accepting applications from qualified technology partners.